Clin Mol Hepatol.  2022 Oct;28(4):935-938. 10.3350/cmh.2022.0175.

Personalized medicine in nonalcoholic fatty liver disease

Affiliations
  • 1Institute of Medical Research A Lanari, School of Medicine, University of Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
  • 2Department of Molecular Genetics and Biology of Complex Diseases, National Scientific and Technical Research Council (CONICET)-University of Buenos Aires, Institute of Medical Research (IDIM), Ciudad Autónoma de Buenos Aires, Argentina
  • 3Department of Clinical and Molecular Hepatology, National Scientific and Technical Research Council (CONICET)-University of Buenos Aires, Institute of Medical Research (IDIM), Ciudad Autónoma de Buenos Aires, Argentina

Keyword

Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Genetics; PNPLA3; Polygenic risk scores
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr